{"url_path":"/sec/mrkr/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1094038/0001104659-26-062763-index.html","accession_number":"0001104659-26-062763","cik":"0001094038","ticker":"MRKR","issuer_name":"Marker Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1094038/0001104659-26-062763-index.html","primary_entity_key":"0001094038","primary_entity_name":"Marker Therapeutics, Inc."},"word_count":67,"has_tables":true,"body_markdown":"**Item 1.          Legal Proceedings**\n\nFrom time to time, we may become involved in legal proceedings, including those arising in the ordinary course of our business. We are not currently a party to any material legal proceedings, and we are not aware of any pending or threatened legal proceeding against us that we believe could have an adverse effect on our business, operating results, or financial condition.\n\n​"}